Current through Register Vol. 49, No. 9, September, 2024
Section II
Episodes of Care
TOC required
211.100
Episode Definition/Scope of
ServicesA.
Episode
subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
A live birth on a facility claim
C.
Episode
duration:
Episode begins 40 weeks prior to delivery and ends 60 days
after delivery
D.
Episode services:
All medical assistance with a pregnancy-related ICD-9 diagnosis
code is included. Medical assistance related to neonatal care is not
included.
211.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Limited prenatal care
(i.e., pregnancy-related claims) provided between start of episode and 60 days
prior to delivery
B. Delivering
provider did not provide any prenatal services
C. Episode has no professional claim for
delivery
D. Pregnancy-related
conditions: amniotic fluid embolism, obstetric blood clot embolism, placenta
previa, severe preeclampsia, multiple gestation [GREATER THAN OR EQUAL TO]3,
late effect complications of pregnancy/childbirth, puerperal sepsis, suspected
damage to fetus from viral disease in mother, cerebrovascular
disorders
E. Comorbidities: cancer,
cystic fibrosis, congenital cardiovascular disorders, DVT/pulmonary embolism,
other phlebitis and thrombosis, end-stage renal disease, sickle cell, Type I
diabetes
212.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Duration of less than 4
months
B. Small number of medical
and/or pharmacy claims during the episode
C. Beneficiaries with any comorbid behavioral
health condition or developmental disability
D. Beneficiaries age 5 or younger and
beneficiaries age 18 or older at the time of the initial claim
213.100
Episode
Definition/Scope of ServicesA.
Episode subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
Inpatient admission with a primary diagnosis code for heart
failure
C.
Episode duration:
Episodes begin at inpatient admission for heart failure.
Episodes end at the latter of 30 days after the date of discharge for the
triggering admission or the date of discharge for any inpatient readmission
initiated within 30 days of the initial discharge. Episodes shall not exceed 45
days post-discharge from the triggering admission.
D.
Episode
services:
The episode will include all of the following services rendered
within the episode's duration:
1.
Inpatient facility and professional fees for the initial hospitalization and
for all cause readmissions (excluding those defined by Bundled Payments for
Care Improvement (BPCI))
2.
Emergency or observation care
3.
Home health services
4. Skilled
nursing facility care due to acute exacerbation of CHF (services not included
in episode for patients with SNF care in 30 days prior to episode
start)
5. Durable medical
equipment
E.
Continuous Medicaid Enrollment
For the purpose of the CHF episode, the beneficiary must be
enrolled in Medicaid beginning at least 30 days before the start of the episode
and maintain continuous enrollment in Medicaid for the duration of the
episode.
214.100
Episode Definition/Scope of Services
A.
Episode
subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
A surgical procedure for total hip replacement or total knee
replacement
C.
Episode duration:
Episodes begin 30 days prior to the date of admission for the
inpatient hospitalization for the total joint replacement surgery and end 90
days after the date of discharge.
D.
Episode
services:
The following services are included in the episode:
1. From 30 days prior to the date of
admission to the date of the surgery: All evaluation and management, hip- or
knee-related radiology and all labs/imaging/other outpatient services
2. During the triggering procedure: all
medical, inpatient and outpatient services
3. From the date of the surgery to 30 days
after the date of discharge: All cause readmissions (excluding those defined by
Bundled Payments for Care Improvement (BPCI)), non-traumatic revisions,
complications, all follow-up evaluation & management, all emergency
services, all home health and therapy, hip/knee radiology and all
labs/imaging/other outpatient procedures
4. From 31 days to 90 days after the date of
discharge: Readmissions (excluding those defined by BPCI) due to infections and
complications as well as hip or knee-related follow-up evaluation and
management, home health and therapy and labs/imaging/other outpatient
procedures
215.000
OPPOSITIONAL DEFIANT DISORDER
(ODD) EPISODES
215.100
Episode Definition/Scope of Services
A.
Episode
subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
ODD episodes are triggered by three medical claims with a
primary diagnosis of ODD.
C.
Episode
duration:
The standard episode duration is a 90-day period beginning at
the time of the first trigger claim. Claims for a beneficiary are tracked for
180 days following the closure of the 90-day standard episode to determine the
episode remission rate quality metric.
D.
Episode
services:
All claims with a primary diagnosis of ODD. Behavioral health
medications will be excluded from the episode, but utilization of medications
will be tracked as a quality metric for providers "to pass."
Notwithstanding any other provisions in the provider manual,
medical assistance included in an ODD episode shall not be subject to prior
authorization requirements.
215.200
Principal Accountable Provider
Determination of the Principal Accountable Provider (PAP) is
based upon which provider is responsible for the largest number of claims
within the episode.
The provider responsible for the largest number of claims is
designated the PAP. In instances in which two providers are responsible for an
equal number of claims within the episode, the provider whose claims accounted
for a greater proportion of total reimbursement will be designated PAP.
Providers eligible to be PAPs include primary care physicians,
psychiatrists, clinical psychologists, and RSPMI provider organizations.
215.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Beneficiaries not
continuously enrolled in Medicaid during the 90-day episode
B. Beneficiaries with any comorbid behavioral
health condition
C. Beneficiaries
age 5 or younger and beneficiaries age 18 or older at the time of the initial
claim
215.400
Adjustments
An episode with fewer than 10 therapy visits over 30+ days will
not be applied to reduce a PAP's average episode cost but may count toward risk
sharing. PAPs who in an entire performance period have no episodes with 10 or
more therapy visits over 30+ days will not be eligible for gain sharing.
215.500
Quality Measures
A.
Quality
measures "to pass":
1.
Percentage of episodes with completion of either Continuing Care or Quality
Assessment certification - must meet minimum threshold of 90% of
episodes.
2. Percentage of new
episodes (i.e., a PAP's first ODD episode for this beneficiary) in which the
beneficiary received behavioral health medications - must be under maximum
threshold of 20%.
3. Percentage of
repeat episodes (i.e., all episodes other than a PAP's first ODD episode for
this beneficiary) for which the beneficiary received behavioral health
medications - must be equal to 0%.
4. Percentage of episodes resulting in
beneficiary remission (no repeat ODD episode for this beneficiary within 180
days after the end of the episode) - must meet minimum threshold of 40%. If a
PAP has [LESS THAN]5 episodes used for the calculation in a performance period,
the metric becomes a quality measure "to track" - not "to pass".
B.
Quality
measures "to track":
1.
Percentage of episodes with [GREATER THAN]9 visits over [GREATER THAN]30
days
2. Percentage of episodes
certified as non-guideline concordant care
3. Average number of visits per
episode
4. Average number of
behavioral therapy visits per episode
5. Percentage of episodes with [GREATER
THAN]9 therapy sessions over a period of 30+ days and of which [GREATER THAN]7
are family therapy sessions (CPT 90846 OR CPT 90847)
215.600
Thresholds for
Incentive PaymentsA. The acceptable
threshold is $2,671.
B. The
commendable threshold is $1,642.
C.
The gain sharing limit is $984.
D.
The gain sharing percentage is 50%.
E. The risk sharing percentage is
50%.
215.700
Minimum Case Volume
The minimum case volume is 5 cases per 12-month period.
216.000
COLONOSCOPY
EPISODES
216.100
Episode Definition/Scope of Services
A.
Episode
subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
Outpatient colonoscopy procedure (including balloon, biopsy,
polypectomy, etc.) and primary or secondary diagnosis indicating conditions
that require a colonoscopy (e.g., colorectal bleeding, hemorrhoids, anal
fistula, neoplasm of unspecified nature). For a complete list of diagnoses,
please see the code sheet associated with the episode.
C.
Episode
duration:
Episodes begin with the initial consult with the performing
provider (within 30 days prior to procedure) and end 30 days after the
procedure.
D.
Episode services:
The episode will include all of the following services rendered
within the episode's duration:
1.
Within 30-day pre-procedure window: related services beginning on the day of
the first consult with the performing provider, including inpatient and
outpatient facility services, professional services, related medications, and
excluding ER visits on the day of the first visit
2. Within procedure window: colonoscopies
with and without additional procedures, including inpatient and outpatient
facility services, professional services, and related medications, beginning
day of procedure
3. Within 30-day
post-procedure window; related services including inpatient and outpatient
facility services, professional services, related medications, treatment for
post-procedure complications, inpatient post-procedure admission (excluding
those defined by Bundled Payments for Care Improvement (BPCI))
216.200
Principal
Accountable Provider
The Principal Accountable Provider (PAP) for an episode is the
primary provider performing the colonoscopy.
216.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Beneficiaries with select
comorbid conditions within 365 days prior to procedure or during episode (e.g.,
inflammatory bowel disease, select cancers, select transplants, etc.). For a
complete list of comorbidities, please see the code sheet associated with the
episode.
B. Beneficiaries under the
age of 18 or over the age of 64 at the time of the procedure
C. Beneficiaries who are pregnant during the
episode
D. Beneficiaries with dual
enrollment in Medicare/Medicaid (i.e., dual-eligible)
E. Beneficiaries who do not have continuous
Medicaid enrollment for the duration of the episode
F. Beneficiaries who die in the hospital
during the episode
G. Beneficiaries
with patient status "left against medical advice" during the episode
216.400
Adjustments
The cost of this episode is based on a) risk factors (e.g.,
renal failure, diabetes) and b) episode types. Episode types include 1)
colonoscopies with additional procedures, 2) colonoscopies without additional
procedures.
216.500
Quality MeasuresA.
Quality measures "to pass":
1. Cecal intubation rate reported by provider
on an aggregated quarterly basis - must meet minimum threshold of
75%.
2. In at least 80% of valid
episodes, the withdrawal time must be greater than 6 minutes.
B.
Quality
measures "to track":1.
Perforation rate
2. Post
polypectomy/biopsy bleed rate
All of the above quality measures "to pass" require providers
to submit data through the provider portal.
216.600
Thresholds for
Incentive PaymentsA. The acceptable
threshold is $886.
B. The
commendable threshold is $796.
C.
The gain sharing limit is $717.
D.
The gain sharing percentage is 50%.
E. The risk sharing percentage is
50%.
216.700
Minimum Case Volume
The minimum case volume is 5 total cases per 12-month
period.
217.000
TONSILLECTOMY EPISODES
217.100
Episode Definition/Scope of
Services
A.
Episode subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
Episode is triggered by an outpatient tonsillectomy,
adenoidectomy, or adeno-tonsillectomy procedure, and a primary or secondary
diagnosis (Dx1 or Dx2) indicating conditions that require
tonsillectomy/adenoidectomy (e.g., chronic tonsillitis, chronic adenoiditis,
chronic pharyngitis, hypertrophy of tonsils and adenoids, obstructive sleep
apnea, insomnia, peritonsillar abscess). For a complete list of diagnoses,
please see the code sheet associated with the episode.
C.
Episode
duration:
Episodes begin with the initial consult with the performing
provider (within 90 days prior to procedure) and end 30 days after the
procedure.
D.
Episode services:
The following services are included in the episode:
1. Within 90 days prior to procedure: initial
consult with performing provider, and any related services including sleep
studies, head and neck X-rays, and laryngoscopy
2. The tonsillectomy/adenoidectomy
procedure
3. Within 30 days after
procedure: related services including inpatient and outpatient facility
services, professional services, related medications, treatment for
post-procedure complications, and post-procedure admissions (excluding those
defined by Bundled Payments for Care Improvement (BPCI))
217.200
Principal
Accountable Provider
For each episode, the Principal Accountable Provider (PAP) is
the primary provider performing the tonsillectomy/adenoidectomy.
217.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Beneficiaries who are
under the age of 3 or above the age of 21 at the time of the
procedure
B. Beneficiaries with
select comorbid conditions (e.g., Down syndrome, cancer, severe asthma,
cerebral palsy, muscular dystrophy, myopathies). For a complete list of
comorbidities, please see the code sheet associated with the episode.
C. Beneficiaries with an
Uvulopalatopharngoplasty (UPPP) on date of procedure
D. Beneficiaries with a BMI[GREATER
THAN]50
E. Beneficiaries with dual
enrollment in Medicare/Medicaid (i.e., dual-eligible)
F. Beneficiaries who do not have continuous
Medicaid enrollment for the duration of the episode
G. Beneficiaries who die in the hospital
during the episode
H. Beneficiaries
with a patient status of "left against medical advice" during the
episode
217.400
Adjustments
For the purpose of determining a PAP's performance, the total
reimbursement attributable to the PAP is adjusted for tonsillectomy episodes
within certain risk factors (e.g., COPD, asthma), and depending on type. There
are two episode types:
1)
adenoidectomy and
2)
tonsillectomy/adeno-tonsillectomy.
217.500
Quality Measures
A.
Quality measures "to
pass":1. Percent of
episode with administration of intra-operative steroids - must meet minimum
threshold of 85%
B.
Quality measures "to track":
1. Post-operative primary bleed rate (i.e.,
post-procedure admissions or unplanned return to OR due to bleeding within 24
hours of surgery)
2. Post-operative
secondary bleed rate
3. Rate of
antibiotic prescription post-surgery
All of the above quality measures "to pass" require providers
to submit data through the provider portal.
217.600
Thresholds for
Incentive Payments
A. The acceptable
threshold is $1,069.
B. The
commendable threshold is $1,019.
C.
The gain sharing limit is $824.
D.
The gain sharing percentage is 50%.
E. The risk sharing percentage is
50%.
217.700
Minimum Case Volume
The minimum case volume is 5 total cases per 12-month
period.
218.000
CHOLECYSTECTOMY EPISODES
218.100
Episode Definition/Scope of
Services
A.
Episode subtypes:
There are no subtypes for this episode type.
B.
Episode
trigger:
Episode is triggered by open or laparoscopic cholecystectomy
procedure, and a primary or secondary diagnosis (Dx1 or Dx2) indicating
conditions related to cholecystectomy (e.g., cholelithiasis, cholecystitis).
For a complete list of diagnoses, please see the code sheet associated with the
episode.
C.
Episode duration:
Episodes begin with the cholecystectomy procedure and end 90
days post-procedure
D.
Episode services:
The following services are included in the episode:
1. During procedure: Cholecystectomy surgery
and related services (i.e., inpatient and outpatient facility services,
professional services, related medications, treatment for
complications)
2. Within 90 days
post-procedure: related services (i.e., inpatient and outpatient facility
services, professional services, related medications, treatment for
complications)
3. Within 30-day
post-procedure window: related services including inpatient and outpatient
facility services, professional services, related medications, treatment for
post-procedure complications, inpatient post-procedure admission (excluding
those defined by Bundled Payments for Care Improvement (BPCI))
218.200
Principal
Accountable Provider
For each episode, the Principal Accountable Provider (PAP) is
the primary surgeon performing the cholecystectomy.
218.300
Exclusions
Episodes meeting one or more of the following criteria will be
excluded:
A. Beneficiaries who are
less than or equal to the age of 1 or greater than or equal to the age of 65 at
the time of the procedure
B.
Beneficiaries with select comorbid conditions or past procedures within 365
days or 90 days after cholecystectomy (e.g., HIV, cancer, sickle cell anemia,
transplants). For a complete list of comorbidities, please see the code sheet
associated with the episode.
C.
Beneficiaries with a pregnancy 30 days prior to a cholecystectomy procedure to
90 days after said cholecystectomy procedure
D. Beneficiaries with ICU care within 30 days
prior to the cholecystectomy procedure
E. Beneficiaries with acute pancreatitis,
cirrhosis, or cholangitis concurrent with procedure
F. Beneficiaries with open cholecystectomy
procedure (includes laparoscopic converted to open and surgeries initiated
open)
G. Beneficiaries who die in
the hospital during the episode
H.
Beneficiaries with a patient status of "left against medical advice" during the
episode
I. Beneficiaries with dual
enrollment in Medicare/Medicaid (i.e., dual-eligible)
J. Beneficiaries who do not have continuous
Medicaid enrollment for the duration of the episode
218.400
Adjustments
For the purposes of determining a PAP's performance, the total
reimbursement attributable to the PAP is adjusted for: cholecystectomy episodes
in which patients have comorbidities, including indirectly related health
conditions (e.g., acute cholecystitis, common bile duct stones), and episodes
in which patients have an ED admittance prior to procedure.
218.500
Quality Measures
A.
Quality measures "to
pass":1. Percent of
episodes with CT scan prior to cholecystectomy - must be below threshold of
44%
B.
Quality measures "to track":
1. Rate of major complications that occur in
episode, either during procedure or in post-procedure window: common bile duct
injury, abdominal blood vessel injury, bowel injury
2. Number of laparoscopic cholecystectomies
converted to open surgeries
3.
Number of cholecystectomies initiated via open surgery
218.600
Thresholds for
Incentive PaymentsA. The acceptable
threshold is $2,048.
B. The
commendable threshold is $1,614.
C.
The gain sharing limit is $1,190.
D. The gain sharing percentage is
50%.
E. The risk sharing percentage
is 50%.
218.700
Minimum Case Volume
The minimum case volume is 5 total cases per 12-month
period.
Section I
TOC not required 181.000 Incentives to Improve
Care Quality, Efficiency and Economy
A. Definitions
1. An "episode" refers to a defined
collection of related Medicaid-covered health care services provided to a
specific Medicaid beneficiary.
2.
An "episode type" is defined by a diagnosis, health care intervention, or
condition during a specific timeframe (or performance period).
3. "Thresholds" are the upper and lower
reimbursement benchmarks for an episode of care.
B. Medicaid has established a payment
improvement initiative ("payment improvement program") to incentivize improved
care quality, efficiency and economy. The program uses episode-based data to
evaluate the quality, efficiency and economy of care delivered in the course of
the episode, and to apply payment incentives. Please refer to the
Episodes of Care Medicaid Manual for information about specific
episodes.
C. The payment
improvement program is separate from, and does not alter, current methods for
reimbursement.
D. The payment
improvement program promotes efficiency, economy and quality of care by
rewarding high-quality care and outcomes, encouraging clinical effectiveness,
promoting early intervention and coordination to reduce complications and
associated costs, and, when provider referrals are necessary, by encouraging
referral to efficient and economic providers who furnish high-quality
care.
E. All medical assistance
provided in the delivery of care for an episode may be included in the
determination of a supplemental payment incentive under the payment improvement
program.
F. Payment incentives may
be positive or negative. Incentive payments are calculated and made
retrospectively after care has been completed and reimbursed in accordance with
the published reimbursement methodology. Incentive payments are based on the
aggregate of valid, paid claims across a provider's episodes and are not
relatable to any individual provider claim for payment.
G. Medicaid establishes episode definitions,
levels of supplemental incentive payments and appropriate quality measures
based on evidence-based practices. To identify evidence-based practices,
Medicaid shall consider clinical information furnished by Arkansas providers of
the care and services typically rendered during the episode of care, and may
also consider input from one or more quality improvement organizations
("QIO's") or QIO-like entities, peer-reviewed medical literature, or any
combination thereof.
H. Principal
Accountable Providers
The principal accountable provider(s) (PAPs) for each episode
is/are identified in the section defining the episode. In some cases, Medicaid
may identify PAPs after an episode is complete using algorithms described in
the episode definition.
I.
Supplemental Payment Incentives
For each PAP for each applicable episode type:
1. Performance will be aggregated and
assessed over a specified period of time ("performance period"). For each PAP,
the average reimbursement across all relevant episodes completed during the
performance period will be calculated, based on the set of services included in
the episode definition published and made available to providers.
2. Some episodes may be excluded and
reimbursement for some episodes may be adjusted in this calculation, based on
clinical or other factors, as described in the definition of each
episode.
3. The average adjusted
reimbursement of all episodes for the PAP during the performance period will be
compared to thresholds established by Medicaid with advice from
providers.
4. If the average
adjusted episode reimbursement is lower than the commendable threshold and the
PAP has documented that the quality requirements established by Medicaid for
each episode type have been met, Medicaid will make a positive supplemental
payment to the PAP. This payment will be equal to the difference between the
average adjusted episode reimbursement and the commendable threshold,
multiplied by the number of episodes included in the calculation and multiplied
by a gain sharing percentage for the episode. Where necessary, a gain sharing
limit will be established to avoid incentives for underutilization. PAPs with
average adjusted episode reimbursement lower than the gain sharing limit will
receive a supplemental payment calculated as though their average adjusted
episode reimbursement were equal to the gain sharing limit.
5. If the average episode reimbursement is
higher than the acceptable threshold, the PAP will incur a negative
supplemental payment. This payment to Medicaid will be equal to the difference
between the acceptable threshold and the average adjusted episode
reimbursement, multiplied by the number of episodes included in the calculation
and multiplied by a risk sharing percentage defined by Medicaid for the
episode.
J. Principles
for determining "thresholds"
1. The threshold
process aims to incentivize high-quality clinical care delivered efficiently,
and to consider several factors including the potential to improve patient
access, the impact on provider economics and the level and type of practice
pattern changes required for performance improvement.
2. The acceptable threshold is set such that
average cost per episode above the acceptable threshold reflects unacceptable
performance, which could result from a large variation from typical performance
without clinical justification (e.g., individual provider variation) or from
system-wide variance from widely accepted clinical standards.
3. The commendable threshold is set such that
outperforming the commendable threshold represents quality care provided at a
lower total reimbursement, which would result from care at meaningfully better
than current average reimbursement in Arkansas, consistent with good medical
outcomes. Medicaid may take into consideration what a clinically feasible
target would be, as demonstrated by historical reimbursement variance in
Arkansas.
4. The gain-sharing limit
is set to avoid the risk of incentivizing care delivery at a cost that could
compromise quality.
5. The gain and
risk sharing percentages aim to recognize required provider investment in
practice change and will be set at a sustainable level for Medicaid.
K. Outlier Patient Exclusions
Calculation of average adjusted episode reimbursement for each
PAP will exclude outlier patients who have extraordinarily high risk/severity
so that one or a few cases do not meaningfully misrepresent a provider's
performance across the provider's broader patient population.
L. Provider-level adjustments
1. Supplemental payment incentives for each
PAP take into account provider-level adjustments, which may include stop-loss
provisions, adjustments for cost-based facilities, adjustments or exclusions
for providers with low case volume or any combination thereof.
2. Stop-loss protection: Unless provided
otherwise for a specific episode of care, a provider's net negative incentive
adjustment (total positive adjustments minus total negative adjustments) for
all episodes of care during any performance period shall not exceed ten percent
(10%) of the provider's gross Medicaid reimbursements during that performance
period.
3. Temporary stop-loss
provisions may apply when necessary to ensure access to care.
4. Providers that receive cost-based or
PPS-based reimbursement are reimbursed as specified in the corresponding
provider manual(s), but are subject to positive and negative supplemental
payment incentives in order to achieve statewide improvement in quality and
efficiency. For episodes including services furnished by providers who receive
at exceptional reimbursement levels, reimbursements attributed to PAPs for the
purpose of calculating performance are computed as if the provider did not
receive exceptional reimbursement.
5. Minimum case volume thresholds exclude
from supplemental payment incentives those providers whose case volume includes
too few cases to generate a robust measure of performance. Medicaid will set a
minimum case volume for each episode type. PAPs who do not meet the minimum
case volume for an episode type will not be eligible for positive or negative
supplemental payments for that episode type.
M. Quality
1. For each episode type, there will be a set
of quality metrics "to pass" and a set of quality metrics "to track." These
quality metrics may be based on claims data or based on additional data
specified by Medicaid, which PAPs will be required to report.
2. To quality for positive supplemental
payments, PAPs must report all required data and meet specific thresholds for
the quality metrics "to pass."
3.
Providers who do not report data or who do not meet minimum quality thresholds
may still incur negative supplemental payments if their average adjusted
episode reimbursement exceeds the acceptable threshold.
N. Consideration of the aggregate cost and
quality of care is not a retrospective review of the medical necessity of care
rendered to any particular patient, nor is such consideration intended to
supplant any retrospective review or other program integrity
activity.